About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Rxrbtm1Pcn
targeted mutation 1, Pierre Chambon
MGI:3611570
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Rxratm1Ipc/Rxratm4Ipc
Rxrbtm1Mma/Rxrbtm1Pcn
Tg(KRT14-cre/ERT2)1Ipc/0
involves: 129S2/SvPas MGI:3622670
cn2
Rxratm4Ipc/Rxratm4Ipc
Rxrbtm1Pcn/Rxrbtm1Pcn
Tg(KRT14-cre/ERT2)1Ipc/0
involves: 129S2/SvPas MGI:3622669
cn3
Rxratm4Ipc/Rxratm4Ipc
Rxrbtm1Pcn/Rxrbtm1Pcn
Tg(KRT14-cre)1Ipc/0
involves: 129S2/SvPas * C57BL/6 * SJL MGI:3629395
cn4
Rxratm1Ipc/Rxratm4Ipc
Rxrbtm1Mma/Rxrbtm1Pcn
Tg(KRT14-cre)1Ipc/0
involves: 129S2/SvPas * C57BL/6 * SJL MGI:3629408
cn5
Rxrbtm1Pcn/Rxrbtm1Pcn
Tg(KRT14-cre)1Ipc/0
involves: C57BL/6 * SJL MGI:3629396


Genotype
MGI:3622670
cn1
Allelic
Composition
Rxratm1Ipc/Rxratm4Ipc
Rxrbtm1Mma/Rxrbtm1Pcn
Tg(KRT14-cre/ERT2)1Ipc/0
Genetic
Background
involves: 129S2/SvPas
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rxratm1Ipc mutation (0 available); any Rxra mutation (30 available)
Rxratm4Ipc mutation (0 available); any Rxra mutation (30 available)
Rxrbtm1Mma mutation (0 available); any Rxrb mutation (27 available)
Rxrbtm1Pcn mutation (0 available); any Rxrb mutation (27 available)
Tg(KRT14-cre/ERT2)1Ipc mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Rxratm1Ipc/Rxratm4Ipc Rxrbtm1Mma/Rxrbtm1Pcn Tg(KRT14-cre/ERT2)1Ipc/0 mice develop alopecia but no skin inflammation while Rxratm4Ipc/Rxratm4Ipc Rxrbtm1Pcn/Rxrbtm1Pcn Tg(KRT14-cre/ERT2)1Ipc/0 mice show both hair loss and skin inflammation

immune system
• at week 12, IgG and IgE levels are 5- and 4-fold higher respectively in mutants compared to wild-type

integument
• mice develop early hair loss observed around the eyes and the dorsal skin at weeks 3 to 5
• phenotype of adult mutant epidermis is identical to that observed in Rargtm1Ipc newborns
• at week 5, mice show a dense dermal hyperplasia
• mutants show a weaker infiltration of the dermis
• in mutants neutral lipids are distributed unevenly along the cornified layer of the epidermis
• with treatment with the Ppard agonist L165041, epidermis of adult mice is similar to control mice with lipids forming a continuous ribbon on top of the cornified layer
• granular keratinocytes in mutants contain vesicles devoid of lamellae or with disorganized lamellae
• disorganized lamellae form aggregates at the apical pole of granular keratinocytes
• at week 5, mice show a dense dermal hyperplasia and hyperplasic epidermis

hematopoietic system
• at week 12, IgG and IgE levels are 5- and 4-fold higher respectively in mutants compared to wild-type




Genotype
MGI:3622669
cn2
Allelic
Composition
Rxratm4Ipc/Rxratm4Ipc
Rxrbtm1Pcn/Rxrbtm1Pcn
Tg(KRT14-cre/ERT2)1Ipc/0
Genetic
Background
involves: 129S2/SvPas
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rxratm4Ipc mutation (0 available); any Rxra mutation (30 available)
Rxrbtm1Pcn mutation (0 available); any Rxrb mutation (27 available)
Tg(KRT14-cre/ERT2)1Ipc mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Rxratm4Ipc/Rxratm4Ipc Rxrbtm1Pcn/Rxrbtm1Pcn Tg(KRT14-cre/ERT2)1Ipc/0 mice develop a chronic skin inflammation

immune system
• after weeks 2-8, mutants develop progressive splenomegaly
• mutant ears display reddening, swelling and scaling at week 2; by week 24, all mutants have swollen and red ears and 60% have developed ulcerations and crusts in the ear
• total WBC counts are 24500 cells in mutants compared to 9700 cells in controls; eosinophils and neutrophils are increased relative to control
• mutants display hyperplasia of regional lymph nodes
• at weeks 2 and 24, cervical lymph nodes are enlarged 2- and 10-fold respectively
• adult mice develop a spontaneous dermatitis that occurs predominantly on and behind the ears, on the face, and in the neck and back regions

hematopoietic system
• after weeks 2-8, mutants develop progressive splenomegaly
• total WBC counts are 24500 cells in mutants compared to 9700 cells in controls; eosinophils and neutrophils are increased relative to control

liver/biliary system
• at week 20, 50% of mutants have livers that are enlarged up to 2-fold

hearing/vestibular/ear
• mutant ears display reddening, swelling and scaling at week 2; by week 24, all mutants have swollen and red ears and 60% have developed ulcerations and crusts in the ear

integument
• adult mice develop a spontaneous dermatitis that occurs predominantly on and behind the ears, on the face, and in the neck and back regions
• mutants display progressive alopecia that is obvious by 6 weeks after Tamoxifen administration at 6 weeks of age
• infiltrated cells and dilated blood vessels are present in the dermis; by week 24, there is heavy dermal infiltrate in mutant ears
• at week 2, ear and dorsal skin biopsies show epidermal hyperplasia; at week 12. ears exhibit high epidermal hyperplasia
• at week 6-8, mice exhibit dry skin on the trunk
• at week 6-8, mice exhibit scaly skin on the trunk
• at week 6-8, small lesions are macroscopically visible on the trunk

growth/size/body
• at week 20, 50% of mutants have livers that are enlarged up to 2-fold
• after weeks 2-8, mutants develop progressive splenomegaly




Genotype
MGI:3629395
cn3
Allelic
Composition
Rxratm4Ipc/Rxratm4Ipc
Rxrbtm1Pcn/Rxrbtm1Pcn
Tg(KRT14-cre)1Ipc/0
Genetic
Background
involves: 129S2/SvPas * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rxratm4Ipc mutation (0 available); any Rxra mutation (30 available)
Rxrbtm1Pcn mutation (0 available); any Rxrb mutation (27 available)
Tg(KRT14-cre)1Ipc mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• there is a marked decrease in cholesterol in newborns

integument
• in mutants neutral lipids are distributed unevenly along the cornified layer of the epidermis
• granular keratinocytes in mutants contain vesicles devoid of lamellae or with disorganized lamellae
• disorganized lamellae form aggregates at the apical pole of granular keratinocytes
• newborns have skin with glossy appearance




Genotype
MGI:3629408
cn4
Allelic
Composition
Rxratm1Ipc/Rxratm4Ipc
Rxrbtm1Mma/Rxrbtm1Pcn
Tg(KRT14-cre)1Ipc/0
Genetic
Background
involves: 129S2/SvPas * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rxratm1Ipc mutation (0 available); any Rxra mutation (30 available)
Rxratm4Ipc mutation (0 available); any Rxra mutation (30 available)
Rxrbtm1Mma mutation (0 available); any Rxrb mutation (27 available)
Rxrbtm1Pcn mutation (0 available); any Rxrb mutation (27 available)
Tg(KRT14-cre)1Ipc mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
integument
• phenotype of newborn mutant epidermis is identical to that observed in Rargtm1Ipc newborns
• in mutants neutral lipids are distributed unevenly along the cornified layer of the epidermis
• granular keratinocytes in mutants contain vesicles devoid of lamellae or with disorganized lamellae
• disorganized lamellae form aggregates at the apical pole of granular keratinocytes
• skin of newborns appears dull




Genotype
MGI:3629396
cn5
Allelic
Composition
Rxrbtm1Pcn/Rxrbtm1Pcn
Tg(KRT14-cre)1Ipc/0
Genetic
Background
involves: C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rxrbtm1Pcn mutation (0 available); any Rxrb mutation (27 available)
Tg(KRT14-cre)1Ipc mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• no epidermal phenotype is apparent





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/22/2024
MGI 6.24
The Jackson Laboratory